Trial record 1 of 40 for:    phase I study of mozobil
Previous Study | Return to List | Next Study

A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT00967785
Recruitment Status : Recruiting
First Posted : August 28, 2009
Last Update Posted : June 13, 2018
Information provided by (Responsible Party):
National Institutes of Health Clinical Center (CC) ( National Institute of Allergy and Infectious Diseases (NIAID) )

No Study Results Posted on for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : September 30, 2021
  Estimated Study Completion Date : December 31, 2021
Publications automatically indexed to this study by Identifier (NCT Number):